Diabetes drugs Word Scramble
|
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
| Drug class | Types | Action | Clinical use | Toxicities |
| Biguanides: | Metformin | Exact mechanism is unknown. Decrease gluconeogensis, increase glycolysis, decrease glucose. (insulin sensitizer) | Oral hypoglycemic. (type 1,2) | Lactic acidosis |
| Glitazones: | Pioglitazone, Rosiglitazone | Increase response to insulin by causing release of adiponectins | monotherapy in type 2 | Weight gain, edema. Hepatoxicity, CV toxicity |
| Alpha-glucosidase inhibitors | Acarbose, Miglitol | Inhibit intestinal brush-border alpha glucosidases. | Type 1, 2 | GI disturbances |
| Mimemtics | Pramlintide | decreased glucagon | type 2 | hypoglycemia, nausea, diarrhea |
| GLP-1 | Exenatide | increased insulin, decreased glucagon | Type 2 | Nausea, vomiting; pancreatitis |
| Orlistat | Alters fat metabolism by inhibitng pancreatic lipases | long-term obesity management (in conjunction with modified diet) | Steatorrhea, GI discomfort, reduced absorption of fat-soluble vitamins, headache | |
| Sibutramine | sympathomimetic serotonin and NE reuptake inhibitor | short-term, long-term obesity management | HTN, tachycardia | |
| Propylthiouracil, methimazole | Inhibit organifiation and coupling of thyroid hormone synthesis. Decreased conversion of T4, T3 | Hyperthyroidism | Skin rash, agranulocytosis (rare), aplastic anemia | |
| GH | GH deficiency, Turner's syndrome | |||
| Somatostatin | Acromegaly, carcinoid, gastrinoma, glucagonoma | |||
| Oxytocin | stimulates labor, uterine contractions, milk let-down, controls uterine hemorrhage | |||
| ADH | Pituitary (central, nephrogenic) DI | |||
| Levothyroxine, triiodothyronine | Thyroxine replacement | Hypothyroidism, myxedema | Tachycardia, heat intolerance, tremors, arrythmias | |
| Glucocorticoids | Hydrocortisone, prednisone, triamcinolone, dexamethasone, beclomethasone | decrease the production leukotrienes, PGE by inhibiting phospholipase A2 and expression COX-2 | Addison's disease, inflammation, immune suppression, asthma | Iatrogenic Cushing's synrome- buffalo hump, moon facies, truncal obesity, muscle wasting, thin skin, bruisability, OA, adrenocortical atrophy, peptic ulcers, diabetes (chronic) |
| Demeclocycline | ADH antagonist (member of tetracycline) | Diabetes insipidus, SIADH | Photosensitivity, abnormalities of bone and teeth | |
| Insulin: short, medium long acting | Short acting: Lispro, Aspart, regular; intermediate: NPH, Long-acting: glargine, determir | Bind insulin receptor; Liver: glycogenolysis, muscle: glycogenolysis, protein synthesis, K uptake, Fats: TG storage | Type 1, 2. hyperkalemia, stress induced hyperglycemia | Hypoglycemia, hypersensitivity |
| Sulfonylurea: 1st and 2nd generation | 1st generation: Tolbutamide, Chlorpropamide; Second generation: Glyburid, Glimepiride, Glipizide | Close K channel in B cell membrane, so cell depolarizes --> triggering of insulin release | Stimulates release of endogenous insulin in type 2. Require some islet function (no DM 1) | Bad for people with sulfa allergiesFirst generation: disulfiram-like effects; 2nd: hypoglycemia |
Created by:
ddecampo
Popular USMLE sets